Indication:
This product is indicated for the treatment of advanced epithelial ovarian cancer:
•First-line therapy;
•Second-line therapy following failure of other treatments.
This product is also indicated for the treatment of small cell lung cancer and squamous cell carcinoma of the head and neck.